Herbas VPB

Print
EN | LT
LT - Imunokonjugatai, nukreipti į CD138, ir jų panaudojimas
EN - IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
C07K 16/30 (2006.01)
A61P 35/00 (2006.01)
A61K 47/48 (2006.01)
A61K 39/395 (2006.01)
European patent
(11) Number of the document 2242772
(13) Kind of document T
(96) European patent application number 08865838.0
Date of filing the European patent application 2008-12-23
(97) Date of publication of the European application 2010-10-27
(45) Date of publication and mention of the grant of the patent 2014-11-26
(46) Date of publication of the claims translation 2015-03-25
PCT application
(86) Number PCT/EP2008/068267
Date 2008-12-23
PCT application publication
(87) Number WO 2009/080830
Date 2009-07-02
Priority applications
(30) Number Date Country code
16620 P 2007-12-26 US
87466 P 2008-08-08 US
87590 P 2008-08-08 US
Inventors
(72)
KRAUS, Elmar, DE
BRUECHER, Christoph, DE
DAELKEN, Benjamin, DE
ZENG, Steffen, DE
OSTERROTH, Frank, DE
UHEREK, Christoph, DE
AIGNER, Silke, DE
GERMER, Matthias, DE
SCHULZ, Gregor, DE
HAEDER, Thomas, DE
Grantee
(73) Biotest AG, Landsteinerstr. 5, 63303 Dreieich, DE
Immunogen, Inc., 830 Winter Street, Waltham, MA 02451-1477, US
Attorney or representative
(74) Ramunė GARŠVIENĖ, Dūkštų g. 28-20, LT-07171 Vilnius, LT
Title
(54) Imunokonjugatai, nukreipti į CD138, ir jų panaudojimas
  IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF
Last renewal fee
Payment date Validity (years) Amount
2018-11-26 11 289.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2019-12-23